
1. malar j. 2019 nov 27;18(1):380. doi: 10.1186/s12936-019-3010-9.

multiplex malaria antigen detection bead-based assay molecular
confirmation pcr shows evidence pfhrp2 pfhrp3 deletion haiti.

herman c(1)(2), huber cs(1), jones s(1)(3), steinhardt l(1), plucinski mm(4),
lemoine jf(5), chang m(1), barnwell jw(1), udhayakumar v(1), rogier e(6).

author information: 
(1)malaria branch, division parasitic diseases malaria, centers for
disease control prevention, atlanta, ga, usa.
(2)cdc foundation (cdcf), atlanta, ga, usa.
(3)atlanta research education foundation (aref), atlanta, ga, usa.
(4)u.s. president's malaria initiative, centers disease control and
prevention, atlanta, ga, usa.
(5)programme national de contrôle de la malaria/mspp, port-au-prince, haiti.
(6)malaria branch, division parasitic diseases malaria, centers for
disease control prevention, atlanta, ga, usa. erogier@cdc.gov.

background: plasmodium falciparum parasite human malaria that
produces histidine-rich protein 2 3 (hrp2/3) antigens. currently, hrp2/3 
are widely used malaria rapid diagnostic tests (rdts), several global
reports recently emerged showing genetic deletion one these
antigens parasites. deletion antigens could pose major concern 
p. falciparum diagnosis haiti currently uses rdts based solely the
detection hrp2/3 antigens.
methods: september 2012 february 2014, dried blood spots (dbs) 
collected haiti 9317 febrile patients presenting 17 health facilities 
in 5 departments throughout country part bed net intervention study. 
all dbs rdt positive persons random sampling dbs rdt negative 
persons assayed p. falciparum dna nested pet-pcr (n = 2695
total). pcr positive samples (n = 331) subset pcr negative samples
(n = 95) assayed three malaria antigens multiplex bead assay:
pan-plasmodium aldolase (paldo), pan-plasmodium lactate dehydrogenase (pldh), and
hrp2/3. samples positive p. falciparum dna, negative hrp2/3
antigens tested nested pcr pfhrp2 pfhrp3 gene deletions.
results: 2695 dbs tested plasmodium dna, 345 (12.8%) originally found
to positive p. falciparum dna; 331 dbs available antigen 
detection. these, 266 (80.4%) positive paldo, 221 (66.8%) positive
for pldh, 324 (97.9%) positive hrp2/3 antigens. seven samples (2.1%)
positive p. falciparum dna positive three antigens by
the bead assay, investigated potential pfhrp2/3 gene deletion by
pcr. samples either successfully amplified pfhrp2/3 genes an
estimated parasite density low sufficient dna perform successful
genotyping.
conclusions: malaria positive samples multiple haitian sites found to
contain hrp2/3 antigens, evidence found pfhrp2/3 deletions.
malaria rdts based detection hrp2/3 antigens remain reliable p.
falciparum diagnostic tool haiti works towards malaria elimination.

doi: 10.1186/s12936-019-3010-9 
pmcid: pmc6882344
pmid: 31775743  [indexed medline]

